← Eichor
Study identifier: NCT06788314 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study of Enalapril in Treatment of Venous Malformations

Condition: Venous Malformation · Pain · Quality of Life  ·  Sponsor: Oslo University Hospital

PhasePhase 2
Planned participants12
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to explore if enalapril can be used to treat painful venous malformations. The main question it aims to answer are: \- Can enalapril reduce pain and volume of the malformation and increase quality of life in patients with painful venous malformations? Participants will: Receive a dose of enalapril 5 mg once daily. If it doesn't have effect the dose of enalapril will be increased to 10 mg daily after 3 months. The treatment duration will be 12 months, with an additional follow-up of 12 months. The visit frequency will be after 1, 3, 6,9 and 12 months and then a follow up visit at 18 and 24 months. Approximately 15 participants will be screened to achieve minimum 10 enrolled participants.

This description comes directly from the study's public registry record.

Talk to the study team

Christina Bjerring Opheim, MD and PhD student  ·  +47 23070000  ·  chbjer@ous-hf.no

Nina Haagenrud Schultz, MD, PhD  ·  +47 23070000  ·  nischu@ous-hf.no

Always discuss trial participation with your own doctor first.

Locations (1)

Oslo University Hospital, RikshospitaletOslo, Norway, NorwayRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06788314